Aptamer-functionalized liposomes for targeted cancer therapy
Authors:
- Seyedeh Alia MoosavianSMSeyedeh Alia Moosavian
- Prashant KesharwaniPKPrashant Kesharwani
- Vanshikha SinghVSVanshikha Singh
- Amirhossein SahebkarASAmirhossein Sahebkar
- 27 January 2023
- book chapter
- Published by Elsevier
- p. 141-172
Abstract
No abstract availableThis publication has 156 references indexed in Scilit:
- Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung CancerMolecular Therapy Nucleic Acids, 2013
- Aptamer-Functionalized Nanoparticles for Medical Applications: Challenges and OpportunitiesACS Nano, 2012
- The transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- An RNA Alternative to Human Transferrin: A New Tool for Targeting Human CellsMolecular Therapy Nucleic Acids, 2012
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerExperimental and Molecular Pathology, 2009
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- Effect of Linker Structure on Surface Density of Aptamer Monolayers and Their Corresponding Protein Binding EfficiencyAnalytical Chemistry, 2008
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearanceAdvanced Drug Delivery Reviews, 2008
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences, 2008